Purple Biotech (PPBT) Income towards Parent Company (2014 - 2026)
Purple Biotech (PPBT) reported Income towards Parent Company of $86000.0 for Q1 2026, down 81.02% year-over-year from $453000.0 in Q1 2025, and down 81.02% on a QoQ basis from $453000.0 in Q1 2025.
Purple Biotech (PPBT) has 2 years of Income towards Parent Company data on file, last reported at $86000.0 in Q1 2026.
- Quarterly Income towards Parent Company fell 81.02% year-over-year to $86000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $539000.0 (up 18.98% YoY) and the FY2025 annual result came in at -$26.4 million, down 264.45% from the prior year.
- Income towards Parent Company retreated to $86000.0 in Q1 2026 per PPBT's latest filing, from $453000.0 in the prior quarter.
- Across five years, Income towards Parent Company topped out at $453000.0 in Q1 2025 and bottomed at $86000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86,000.00 |
| Dec 31, 2025 | 23.55 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 453,000.00 |
| Dec 31, 2024 | 410,000.00 |
| Sep 30, 2024 | 663,000.00 |
| Jun 30, 2024 | 2.41 Mn |
| Mar 31, 2024 | 3.78 Mn |
| Dec 31, 2023 | 4.83 Mn |
| Sep 30, 2023 | 5.04 Mn |
| Jun 30, 2023 | 5.14 Mn |
| Mar 31, 2023 | 4.88 Mn |
| Dec 31, 2022 | 6.01 Mn |
| Sep 30, 2022 | 4.82 Mn |
| Jun 30, 2022 | 3.56 Mn |
| Mar 31, 2022 | 7.30 Mn |
| Dec 31, 2021 | 5.07 Mn |
| Sep 30, 2021 | 3.14 Mn |
| Jun 30, 2021 | 3.63 Mn |
| Mar 31, 2021 | 6.55 Mn |
| Dec 31, 2020 | 220,000.00 |
| Dec 31, 2019 | 3.28 Mn |
| Dec 31, 2018 | 349,000.00 |
| Dec 31, 2017 | 6.45 Mn |
| Dec 31, 2016 | 7.05 Mn |
| Dec 31, 2015 | 4.38 Mn |
| Sep 30, 2015 | 548,000.00 |
| Dec 31, 2014 | 600,000.00 |
| Sep 30, 2014 | 982,000.00 |